Sage Journals: Discover world-class research

Open access

Research article

First published 2021

Radium-223 in combination with enzalutamide in metastatic castration-resistant prostate cancer: a multi-centre,phase II open-label study

Raymond S. McDermott, John Greene, John McCaffrey [...]

Therapeutic Advances in Medical Oncology

Open access

Case report

First published 2017-1

Evaluation of Bone Metastases by 18F-Choline PET/CT in a Patient with Castration-Resistant Prostate Cancer Treated with Radium-223

Piera Scalzi, Cinzia Baiocco, Sabrina Genovese [...]

Urologia Journal

Retricted access

Review article

First published 2019-10

Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why

Rosj Gallicchio, Pietro A. Mastrangelo, Anna Nardelli [...]

Tumori Journal

Free access

Review article

First published 2016-6

Clinical experience with radium-223 in the treatment of patients with advanced castrate-resistant prostate cancer and symptomatic bone metastases

Christina Hague, John P. Logue

Therapeutic Advances in Urology

Retricted access

Research article

First published 2020-10

Safety and activity of radium-223 in metastatic castration-resistant prostate cancer: the experience of Istituto Nazionale dei Tumori

Alessandra Raimondi, Pierangela Sepe, Melanie Claps [...]

Tumori Journal

Retricted access

Review article

First published 2015-4

Radium-223 Dichloride

Shane McGann, Evan R. Horton

Annals of Pharmacotherapy

Retricted access

Research article

First published 2014-11

A Unique Drug Distribution Process for Radium Ra 223 Dichloride Injection and Its Implication for Product Quality,Patient Privacy,and Delineation of Professional Responsibilities

Raymond N. Dansereau

Annals of Pharmacotherapy

Retricted access

Review article

First published 2020-09

Review of Radium-223 and Metastatic Castration-Sensitive Prostate Cancer

Savita V. Dandapani, Jeffrey Wong, Przemyslaw Twardowski

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2023-4

Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis

Fabio Turco, Marcello Tucci, Tiziana Angusti [...]

Tumori Journal

Open access

Research article

First published 2023

Prostate-specific antigen doubling time following radium-223 treatment as a predictor of the clinical course in patients with metastatic castration-resistant prostate cancer

Gen Kawaguchi, Kohei Akazawa, Taro Ikeda [...]

Sage Open Medicine

Search results